MIDRIX4-LUNG
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 26, 2019 (NCT04078269)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04078269 | Phase 1 | Aug 26, 2019 | Ghent University, Kom Op Tegen Kanker |
| NCT04082182 | Phase 1 | Aug 26, 2019 | Ghent University, Kom Op Tegen Kanker |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ghent University | Academic/Hospital | 2 | 2 | 1 | 2019 |
| Kom Op Tegen Kanker | Academic/Hospital | 2 | 0 | 1 | 2019 |
2 organizations
Page 1 / 1